Authors: Gallego, O de Mendoza, C Perez-Elias, MJ Guardiola, JM Pedreira, J Dalmau, D Gonzalez, J Moreno, A Arribas, JR Rubio, A Garcia-Arata, I Leal, M Domingo, P Soriano, V

Citation: O. Gallego et al., Drug resistance in patients experiencing early virological failure under atriple combination including indinavir, AIDS, 15(13), 2001, pp. 1701-1706

Authors: Garcia, F Alonso, MM Romeu, J Knobel, H Arrizabalaga, J Ferrer, E Dalmau, D Ruiz, I Vidal, F Frances, A Segura, F Gomez-Sirvent, JL Cruceta, A Clotet, B Pumarola, T Gallart, T O'Brien, WA Miro, JM Gatell, JM

Citation: F. Garcia et al., Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish Earth-2 Study, J ACQ IMM D, 25(1), 2000, pp. 26-35

Authors: Garcia, F Knobel, H Sambeat, MA Arrizabalaga, J Aranda, M Romeu, J Dalmau, D Segura, F Gomez-Sirvent, JL Ferrer, E Cruceta, A Gallart, T Pumarola, T Miro, JM Gatell, JM

Citation: F. Garcia et al., Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study, AIDS, 14(16), 2000, pp. 2485-2494

Authors: Prats, G Navarro, F Mirelis, B Dalmau, D Margall, N Coll, P Stell, A Johnson, JR

Citation: G. Prats et al., Escherichia coli serotype O15 : K52 : H1 as a uropathogenic clone, J CLIN MICR, 38(1), 2000, pp. 201-209

Authors: Garcia, F Romeu, J Grau, I Sambeat, MA Dalmau, D Knobel, H Gomez-Sirvent, JL Arrizabalaga, J Cruceta, A Clotet, B Podzamczer, D Pumarola, T Gallart, T O'Brien, WA Miro, JM Gatell, JM

Citation: F. Garcia et al., A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study, AIDS, 13(17), 1999, pp. 2377-2388

Authors: Dalmau, D Layrargues, GP Fenyves, D Willems, B Turgeon, F Turgeon, P

Citation: D. Dalmau et al., Cefotaxime, desacetyl-cefotaxime, and bactericidal activity in spontaneousbacterial peritonitis, J INFEC DIS, 180(5), 1999, pp. 1597-1602